ProCE Banner Activity

HER2 Alterations and Testing in NSCLC

Slideset

Download this slideset for expert perspectives and guidance on HER2 testing to inform targeted therapy for patients with non-small-cell lung cancer.

Released: March 25, 2025

Expiration: March 24, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Jazz Pharmaceuticals.

AstraZeneca

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals